{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:45:09Z","timestamp":1757619909136,"version":"3.44.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cholangiocarcinoma (CHOL) has a poor prognosis due to its asymptomatic progression, challenges in early detection, and limited treatment options. The lncRNA LUCAT1 is highly expressed in several cancers, including lung, gastric, ovarian, and osteosarcoma tissues.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>This study investigates the potential of LUCAT1 as a diagnostic and prognostic biomarker for CHOL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>In this study, we collected tumor tissues and adjacent tumor healthy tissues from 83 CHOL patients. LUCAT1 expression was quantified in CHOL tissues and cell lines via RT-qPCR. Diagnostic and prognostic significance was assessed through ROC curves, Kaplan-Meier survival analysis, and Cox regression models. The biological effects of LUCAT1 on cell proliferation and migration were examined using QBC939 and HuCCT1 cells with transfection assays. The regulatory interaction between LUCAT1 and miR-141-3p was validated using a dual-luciferase reporter assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Elevated expression of LUCAT1 was observed in CHOL tumor tissues and human cholangiocarcinoma cells, correlating with tumor size, CA-19-9 levels, and TNM stage. The ROC curve, with an AUC of 0.908 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), effectively distinguished CHOL tumor tissues from adjacent non-tumor tissues. And its sensitivity and specificity in distinguishing CHOL tissues from normal tissues were 88.5% and 89.2%, respectively. Survival analyses linked LUCAT1 overexpression to poorer patient outcomes. Silencing LUCAT1 impaired the proliferation and migration of QBC939 and HuCCT1 cells. Dual-luciferase assay confirmed the regulatory relationship between miR-141-3p and LUCAT1. Inhibition of miR-141-3p reversed the effect of LUCAT1 on the proliferation and migration of QBC939 and HuCCT1 cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>LUCAT1 demonstrates significant diagnostic and prognostic potential and could serve as a novel biomarker for CHOL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00512-6","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T14:00:49Z","timestamp":1753538449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA LUCAT1 as a prognostic biomarker in cholangiocarcinoma through targeting miR-141-3p: clinical and functional insights"],"prefix":"10.1186","volume":"162","author":[{"given":"Yuxin","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengcheng","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanbao","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zouxiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"issue":"9","key":"512_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","volume":"8","author":"B Blechacz","year":"2011","unstructured":"Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8(9):512\u201322.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9935","key":"512_CR2","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma Lancet. 2014;383(9935):2168\u201379.","journal-title":"Cholangiocarcinoma Lancet"},{"issue":"6","key":"512_CR3","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jhep.2006.09.001","volume":"45","author":"H Malhi","year":"2006","unstructured":"Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in Understanding a deadly old disease. J Hepatol. 2006;45(6):856\u201367.","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"512_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/liv.14093","volume":"39","author":"T Kendall","year":"2019","unstructured":"Kendall T, Verheij J, Gaudio E, Evert M, Guido M, Goeppert B, et al. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):7\u201318.","journal-title":"Liver Int"},{"key":"512_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijid.2021.12.347","volume":"116","author":"R Rodpai","year":"2022","unstructured":"Rodpai R, Luvira V, Sadaow L, Sukeepaisarnjaroen W, Kitkhuandee A, Paonariang K, et al. Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis. Int J Infect Dis. 2022;116:80\u20134.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"512_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.clinre.2019.06.008","volume":"44","author":"Z Qian","year":"2020","unstructured":"Qian Z, Hu W, Lv Z, Liu H, Chen D, Wang Y, et al. PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma. Clin Res Hepatol Gastroenterol. 2020;44(2):162\u201373.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"512_CR7","doi-asserted-by":"publisher","first-page":"868034","DOI":"10.3389\/fonc.2022.868034","volume":"12","author":"N Wang","year":"2022","unstructured":"Wang N, Huang A, Kuang B, Xiao Y, Xiao Y, Ma H. Progress in radiotherapy for cholangiocarcinoma. Front Oncol. 2022;12:868034.","journal-title":"Front Oncol"},{"key":"512_CR8","doi-asserted-by":"publisher","first-page":"156436","DOI":"10.1016\/j.phymed.2025.156436","volume":"138","author":"S Gao","year":"2025","unstructured":"Gao S, Wang W, Li J, Wang Y, Shan Y, Tan H. Unveiling polysaccharides of Houttuynia cordata thunb.: extraction, purification, structure, bioactivities, and structure-activity relationships. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2025;138:156436.","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"key":"512_CR9","doi-asserted-by":"publisher","first-page":"119200","DOI":"10.1016\/j.jep.2024.119200","volume":"340","author":"S Gao","year":"2025","unstructured":"Gao S, Li J, Wang W, Wang Y, Shan Y, Tan H. Rabdosia rubescens (Hemsl.) H. Hara: A potent anti-tumor herbal remedy - Botany, phytochemistry, and clinical applications and insights. J Ethnopharmacol. 2025;340:119200.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"512_CR10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1055\/a-1161-3985","volume":"58","author":"D Walter","year":"2020","unstructured":"Walter D, Trojan J, Waidmann O. [Systemic chemotherapy of gallbladder carcinoma - simply the same as for cholangiocarcinoma?]. Z Gastroenterol. 2020;58(6):583\u20139.","journal-title":"Z Gastroenterol"},{"key":"512_CR11","doi-asserted-by":"publisher","first-page":"104235","DOI":"10.1016\/j.critrevonc.2023.104235","volume":"194","author":"J Liu","year":"2024","unstructured":"Liu J, Shu J. Immunotherapy and targeted therapy for cholangiocarcinoma: artificial intelligence research in imaging. Crit Rev Oncol\/Hematol. 2024;194:104235.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"Pt 4","key":"512_CR12","doi-asserted-by":"publisher","first-page":"136472","DOI":"10.1016\/j.ijbiomac.2024.136472","volume":"281","author":"S Gao","year":"2024","unstructured":"Gao S, Shan Y, Wang Y, Wang W, Li J, Tan H. Polysaccharides from Lonicera japonica thunb.: extraction, purification, structural features and biological activities-A review. Int J Biol Macromol. 2024;281(Pt 4):136472.","journal-title":"Int J Biol Macromol"},{"key":"512_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-pathol-030220-020455","volume":"16","author":"PM Rodrigues","year":"2021","unstructured":"Rodrigues PM, Olaizola P, Paiva NA, Olaizola I, Agirre-Lizaso A, Landa A, et al. Pathogenesis of cholangiocarcinoma. Annu Rev Pathol. 2021;16:433\u201363.","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"512_CR14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"SI Ilyas","year":"2013","unstructured":"Ilyas SI, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145(6):1215\u201329.","journal-title":"Gastroenterology"},{"issue":"10","key":"512_CR15","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1111\/cas.14151","volume":"110","author":"T Miyata","year":"2019","unstructured":"Miyata T, Yamashita YI, Yoshizumi T, Shiraishi M, Ohta M, Eguchi S, et al. CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis. Cancer Sci. 2019;110(10):3197\u2013203.","journal-title":"Cancer Sci"},{"issue":"10","key":"512_CR16","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1111\/jcmm.15982","volume":"25","author":"K Zhang","year":"2021","unstructured":"Zhang K, Wang Q, Zhong B, Gong Z. LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR-375 expression. J Cell Mol Med. 2021;25(10):4543\u201350.","journal-title":"J Cell Mol Med"},{"key":"512_CR17","doi-asserted-by":"publisher","first-page":"3931875","DOI":"10.1155\/2023\/3931875","volume":"2023","author":"Y Gao","year":"2023","unstructured":"Gao Y, Zhang S, Gao X. TP73-AS1 rs3737589 polymorphism is associated with the clinical stage of colorectal Cancer. Evid Based Complement Alternat Med. 2023;2023:3931875.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"6","key":"512_CR18","first-page":"1752","volume":"17","author":"XC Wu","year":"2021","unstructured":"Wu XC, Yan WG, Ji ZG, Zheng GY, Liu GH. Long noncoding RNA SNHG20 promotes prostate cancer progression via upregulating DDX17. Arch Med Sci. 2021;17(6):1752\u201365.","journal-title":"Arch Med Sci"},{"issue":"17","key":"512_CR19","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.1111\/jcmm.16690","volume":"25","author":"X Wang","year":"2021","unstructured":"Wang X, Gong Z, Ma L, Wang Q. LncRNA GACAT1 induces tongue squamous cell carcinoma migration and proliferation via miR-149. J Cell Mol Med. 2021;25(17):8215\u201321.","journal-title":"J Cell Mol Med"},{"key":"512_CR20","doi-asserted-by":"crossref","unstructured":"Gao Y, Wang X, Luo H, Chen C, Li J, Sun R et al. Exosomal long Non-Coding ribonucleic acid ribonuclease component of mitochondrial ribonucleic acid processing endoribonuclease is defined as a potential Non-Invasive diagnostic biomarker for bladder Cancer and facilitates tumorigenesis via the miR-206\/G6PD Axis. Cancers (Basel). 2023;15(21):5305.","DOI":"10.3390\/cancers15215305"},{"key":"512_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms21218132","volume":"21","author":"S Mahlab-Aviv","year":"2020","unstructured":"Mahlab-Aviv S, Zohar K, Cohen Y, Peretz AR, Eliyahu T, Linial M, et al. Spliceosome-Associated MicroRNAs signify breast Cancer cells and portray potential novel nuclear targets. Int J Mol Sci. 2020;21:21.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"512_CR22","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/cas.15317","volume":"113","author":"W Hu","year":"2022","unstructured":"Hu W, Yuan L, Zhang X, Ni Y, Hong D, Wang Z, et al. Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma. Cancer Sci. 2022;113(5):1843\u201354.","journal-title":"Cancer Sci"},{"key":"512_CR23","doi-asserted-by":"publisher","first-page":"147974","DOI":"10.1016\/j.gene.2023.147974","volume":"894","author":"Y Cao","year":"2024","unstructured":"Cao Y, Zou Z, Wu X, Li W, Lu Z, Hu J, et al. LUCAT1 inhibits ferroptosis in bladder cancer by regulating the mRNA stability of STAT3. Gene. 2024;894:147974.","journal-title":"Gene"},{"issue":"8","key":"512_CR24","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1093\/neuonc\/noae036","volume":"26","author":"H Huang","year":"2024","unstructured":"Huang H, Shah H, Hao J, Lin J, Prayson RA, Xie L, et al. Long non-coding RNA lung cancer-associated transcript-1 promotes glioblastoma progression by enhancing Hypoxia-inducible factor 1 alpha activity. Neuro Oncol. 2024;26(8):1388\u2013401.","journal-title":"Neuro Oncol"},{"key":"512_CR25","doi-asserted-by":"publisher","first-page":"109201","DOI":"10.1016\/j.biopha.2019.109201","volume":"118","author":"J Chi","year":"2019","unstructured":"Chi J, Liu T, Shi C, Luo H, Wu Z, Xiong B, et al. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p\/YWHAZ axis. Biomed Pharmacother. 2019;118:109201.","journal-title":"Biomed Pharmacother"},{"key":"512_CR26","doi-asserted-by":"publisher","first-page":"833579","DOI":"10.3389\/fcell.2022.833579","volume":"10","author":"L Wang","year":"2022","unstructured":"Wang L, Xie Y, Wang J, Zhang Y, Liu S, Zhan Y, et al. Characterization of a novel LUCAT1\/miR-4316\/VEGF-A Axis in metastasis and Glycolysis of lung adenocarcinoma. Front Cell Dev Biol. 2022;10:833579.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"512_CR27","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cncr.29692","volume":"122","author":"NF Esnaola","year":"2016","unstructured":"Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122(9):1349\u201369.","journal-title":"Cancer"},{"issue":"2","key":"512_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2478\/abm-2024-0009","volume":"18","author":"S Lu","year":"2024","unstructured":"Lu S, Li J. Treatment of cholangiocarcinoma by pGCsiRNA-vascular endothelial growth factor in vivo. Asian Biomed (Res Rev News). 2024;18(2):61\u20138.","journal-title":"Asian Biomed (Res Rev News)"},{"key":"512_CR29","doi-asserted-by":"publisher","first-page":"111158","DOI":"10.1016\/j.biopha.2020.111158","volume":"134","author":"C Xing","year":"2021","unstructured":"Xing C, Sun SG, Yue ZQ, Bai F. Role of LncRNA LUCAT1 in cancer. Biomed Pharmacother. 2021;134:111158.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"512_CR30","doi-asserted-by":"publisher","first-page":"e22087","DOI":"10.1016\/j.heliyon.2023.e22087","volume":"9","author":"G Zhou","year":"2023","unstructured":"Zhou G, He H, Wang X, Gu Q. LncRNA-HANR exacerbates malignant behaviors of cholangiocarcinoma cells through activating Notch pathway. Heliyon. 2023;9(12):e22087.","journal-title":"Heliyon"},{"issue":"8","key":"512_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41419-020-02896-x","volume":"11","author":"H Zhu","year":"2020","unstructured":"Zhu H, Zhai B, He C, Li Z, Gao H, Niu Z, et al. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a\/neuropilin-1 axis. Cell Death Dis. 2020;11(8):637.","journal-title":"Cell Death Dis"},{"issue":"1","key":"512_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12885-021-07838-0","volume":"21","author":"W Zhao","year":"2021","unstructured":"Zhao W, Zhao J, Guo X, Feng Y, Zhang B, Tian L. LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p\/FBP1 axis. BMC Cancer. 2021;21(1):142.","journal-title":"BMC Cancer"},{"issue":"4","key":"512_CR33","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/cas.13951","volume":"110","author":"Q Zhou","year":"2019","unstructured":"Zhou Q, Hou Z, Zuo S, Zhou X, Feng Y, Sun Y, et al. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52. Cancer Sci. 2019;110(4):1194\u2013207.","journal-title":"Cancer Sci"},{"issue":"17","key":"512_CR34","doi-asserted-by":"publisher","first-page":"28297","DOI":"10.18632\/oncotarget.16044","volume":"8","author":"Y Sun","year":"2017","unstructured":"Sun Y, Jin SD, Zhu Q, Han L, Feng J, Lu XY, et al. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression. Oncotarget. 2017;8(17):28297\u2013311.","journal-title":"Oncotarget"},{"key":"512_CR35","doi-asserted-by":"crossref","unstructured":"Mou E, Wang H. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702. Biosci Rep. 2019;39(9):BSR20190489.","DOI":"10.1042\/BSR20190489"},{"issue":"10","key":"512_CR36","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41419-020-03095-4","volume":"11","author":"R Wu","year":"2020","unstructured":"Wu R, Li L, Bai Y, Yu B, Xie C, Wu H, et al. The long noncoding RNA LUCAT1 promotes colorectal cancer cell proliferation by antagonizing nucleolin to regulate MYC expression. Cell Death Dis. 2020;11(10):908.","journal-title":"Cell Death Dis"},{"issue":"1","key":"512_CR37","doi-asserted-by":"publisher","first-page":"2395591","DOI":"10.1080\/07853890.2024.2395591","volume":"56","author":"M Song","year":"2024","unstructured":"Song M, Yang X, Zhang X, Li J, Xu Y, Shi J. The masquelet technique triggers the formation of a network involving lncrna, circrna, mirna, and mRNA during bone repair. Ann Med. 2024;56(1):2395591.","journal-title":"Ann Med"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00512-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00512-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00512-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T01:46:10Z","timestamp":1757295970000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00512-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00512-6","relation":{},"ISSN":["1601-5223"],"issn-type":[{"type":"electronic","value":"1601-5223"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology before the study began. The written informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}